NNNN
Anbio Biotechnology
4.80$
-13.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|
| – | +10.5% | +2.5% | +19.8% | -0.1% | +71.7% | -6.9% | +0.0% | +0.0% | |
| – | +8.6% | +4.0% | +19.2% | -1.2% | +75.3% | -6.9% | +0.0% | +0.0% | |
| – | +48.7% | -8.3% | +6.4% | +14.1% | -46.6% | +23.7% | +0.0% | +0.0% | |
| – | +21.8% | -8.3% | +6.4% | +14.1% | +34.0% | -24.5% | – | – | |
| – | +0.0% | +52,537.8% | +144.8% | -76.9% | +309.7% | -16.2% | +0.0% | +0.0% | |
| – | -100.0% | – | – | – | – | – | – | – | |
| – | -4.9% | -26.0% | -46.9% | +227.8% | -91.1% | -42.9% | +0.0% | +0.0% | |
| – | -4.9% | -26.0% | -46.9% | +227.8% | -91.1% | -42.9% | +0.0% | +0.0% | |
| – | -7.1% | -36.8% | -42.1% | +239.3% | -95.6% | – | – | – | |
| – | +12.3% | +5.2% | +24.3% | -6.6% | +88.1% | -6.8% | +0.0% | +0.0% | |
| – | +12.1% | +5.2% | +24.3% | -6.7% | +43.3% | -4.2% | +0.0% | +0.0% | |
| – | – | +0.0% | +0.0% | +0.0% | +3.8% | +0.0% | 0.0% | +0.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.